Synbodies to Akt1
The present application provides synbodies against AKT1 differing in amino acid sequence, conjugation chemistry, linker/scaffold, or adjunct moiety. The synbodies are useful for diagnosis and treatment of cancer and as research reagents.
JOHNSTON STEPHEN [US]; DIEHNELT CHRIS [US]; GUPTA NIDHI [US]; BELCHER PAUL [US]
Type of Offer:
« More Biotech Patents